HeraMED Limited (ASX: HMD) Webcast Replay
HeraMED (ASX: HMD) is an innovative medical technology company leading the digital transformation of maternity care and developing pregnancy monitoring solutions for home use.
As a part of our ‘The Insiders: Meet the CEOs’ series, CEO & Co-Founder David Groberman, provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 9 June 2021 at 12pm (AEST).
Join the next The Insider: Meet the CEOs webcast
FEATURED SPEAKER
David Groberman
CEO & Co-Founder - HeraMED Limited (ASX: HMD)
HeraMED (ASX: HMD) is an innovative medical technology company leading the digital transformation of maternity care and developing pregnancy monitoring solutions for home use.
Harnessing state-of-the-art technology with superior UX/UI, they are creating solutions that are medically accurate, scientifically optimized, safe and affordable. HeraMED offers a proprietary platform that’s reshaping the Doctor/Patient relationship, using its clinically validated in-home foetal and maternal heart rate monitor, cloud computing, artificial intelligence and social networking dashboard.
